Literature DB >> 27277138

Evolution and Use of Dynamic Transmission Models for Measles and Rubella Risk and Policy Analysis.

Kimberly M Thompson.   

Abstract

The devastation caused by periodic measles outbreaks motivated efforts over more than a century to mathematically model measles disease and transmission. Following the identification of rubella, which similarly presents with fever and rash and causes congenital rubella syndrome (CRS) in infants born to women first infected with rubella early in pregnancy, modelers also began to characterize rubella disease and transmission. Despite the relatively large literature, no comprehensive review to date provides an overview of dynamic transmission models for measles and rubella developed to support risk and policy analysis. This systematic review of the literature identifies quantitative measles and/or rubella dynamic transmission models and characterizes key insights relevant for prospective modeling efforts. Overall, measles and rubella represent some of the relatively simplest viruses to model due to their ability to impact only humans and the apparent life-long immunity that follows survival of infection and/or protection by vaccination, although complexities arise due to maternal antibodies and heterogeneity in mixing and some models considered potential waning immunity and reinfection. This review finds significant underreporting of measles and rubella infections and widespread recognition of the importance of achieving and maintaining high population immunity to stop and prevent measles and rubella transmission. The significantly lower transmissibility of rubella compared to measles implies that all countries could eliminate rubella and CRS by using combination of measles- and rubella-containing vaccines (MRCVs) as they strive to meet regional measles elimination goals, which leads to the recommendation of changing the formulation of national measles-containing vaccines from measles only to MRCV as the standard of care.
© 2016 Society for Risk Analysis.

Entities:  

Keywords:  Measles; model; rubella

Mesh:

Year:  2016        PMID: 27277138     DOI: 10.1111/risa.12637

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  14 in total

1.  Chaotic dynamics in the seasonally forced SIR epidemic model.

Authors:  Pablo G Barrientos; J Ángel Rodríguez; Alfonso Ruiz-Herrera
Journal:  J Math Biol       Date:  2017-04-22       Impact factor: 2.259

2.  Reiteration of the elimination status of measles in the southeast of Iran, 2015.

Authors:  Shahrokh Izadi; Masoome Arabsalmani; Mahdi Mohammadi; Seyed Mehdi Tabatabaei; Ali-Akbar Haghdoost
Journal:  Hum Vaccin Immunother       Date:  2018-09-05       Impact factor: 3.452

3.  Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran.

Authors:  Shahrokh Izadi; Seyed Mohsen Zahraei; Talat Mokhtari-Azad
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 3.452

4.  Improving the Science of Measles Prevention-Will It Make for a Better Immunization Program?

Authors:  Julie Garon; Walter Orenstein
Journal:  PLoS Med       Date:  2016-10-11       Impact factor: 11.069

5.  Mathematical Modeling of "Chronic" Infectious Diseases: Unpacking the Black Box.

Authors:  Anthony T Fojo; Emily A Kendall; Parastu Kasaie; Sourya Shrestha; Thomas A Louis; David W Dowdy
Journal:  Open Forum Infect Dis       Date:  2017-08-14       Impact factor: 4.423

Review 6.  Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies.

Authors:  Melissa M Coughlin; Andrew S Beck; Bettina Bankamp; Paul A Rota
Journal:  Viruses       Date:  2017-01-19       Impact factor: 5.048

7.  Delineating morbillivirus entry, dissemination and airborne transmission by studying in vivo competition of multicolor canine distemper viruses in ferrets.

Authors:  Rory D de Vries; Martin Ludlow; Alwin de Jong; Linda J Rennick; R Joyce Verburgh; Geert van Amerongen; Debby van Riel; Peter R W A van Run; Sander Herfst; Thijs Kuiken; Ron A M Fouchier; Albert D M E Osterhaus; Rik L de Swart; W Paul Duprex
Journal:  PLoS Pathog       Date:  2017-05-08       Impact factor: 6.823

8.  Measles antibody levels among vaccinated and unvaccinated children 6-59 months of age in the Democratic Republic of the Congo, 2013-2014.

Authors:  Hayley R Ashbaugh; James D Cherry; Nicole A Hoff; Reena H Doshi; Vivian H Alfonso; Adva Gadoth; Patrick Mukadi; Stephen G Higgins; Roger Budd; Christina Randall; Guillaume Ngoie Mwamba; Emile Okitolonda-Wemakoy; Jean Jacques Muyembe-Tamfum; Sue K Gerber; Anne W Rimoin
Journal:  Vaccine       Date:  2020-02-24       Impact factor: 3.641

9.  Immune amnesia induced by measles and its effects on concurrent epidemics.

Authors:  Guillermo B Morales; Miguel A Muñoz
Journal:  J R Soc Interface       Date:  2021-06-16       Impact factor: 4.118

10.  Predictors of measles vaccination coverage among children 6-59 months of age in the Democratic Republic of the Congo.

Authors:  Hayley R Ashbaugh; Nicole A Hoff; Reena H Doshi; Vivian H Alfonso; Adva Gadoth; Patrick Mukadi; Emile Okitolonda-Wemakoy; Jean Jacques Muyembe-Tamfum; Sue K Gerber; James D Cherry; Anne W Rimoin
Journal:  Vaccine       Date:  2017-12-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.